Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details
Incyte announces FDA approval for Zynyz™
Incyte announces FDA approval for Zynyz™
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Modality Solutions is proud to have been a part of its cold chain strategy!
Stay on top of the industry trends
You may also like
Amicus Therapeutics announces EC approval for Pombiliti™
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details
Acadia Pharmaceuticals, Inc. announces FDA Approval of Daybue
The team at Acadia Pharmaceuticals Inc. announced FDA Approval on their drug Daybue, for...
read Details